Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2025-01-01
|
| Series: | Clinical and Molecular Hepatology |
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2024-0628.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850045429194948608 |
|---|---|
| author | Binghua Li Jingyuan Wen Zhu Xu Peng Yan Bing Han Decai Yu |
| author_facet | Binghua Li Jingyuan Wen Zhu Xu Peng Yan Bing Han Decai Yu |
| author_sort | Binghua Li |
| collection | DOAJ |
| format | Article |
| id | doaj-art-5cedd165e5e2462b8f83eef50dc1f1f3 |
| institution | DOAJ |
| issn | 2287-2728 2287-285X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Korean Association for the Study of the Liver |
| record_format | Article |
| series | Clinical and Molecular Hepatology |
| spelling | doaj-art-5cedd165e5e2462b8f83eef50dc1f1f32025-08-20T02:54:42ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2025-01-01311e31e3410.3350/cmh.2024.06282040Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinomaBinghua Li0Jingyuan Wen1Zhu Xu2Peng Yan3Bing Han4Decai Yu5 Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China Department of Hepatobiliary Surgery, Innovative Institute of Tumor Immunity and Medicine (ITIM), Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, The First Affiliated Hospital of Anhui Medical University, Hefei, China Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Chinahttp://e-cmh.org/upload/pdf/cmh-2024-0628.pdfhepatocellular carcinomaimmunotherapyatezolizumab plus bevacizumabbiomarkerimmune checkpoint inhibitors |
| spellingShingle | Binghua Li Jingyuan Wen Zhu Xu Peng Yan Bing Han Decai Yu Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma Clinical and Molecular Hepatology hepatocellular carcinoma immunotherapy atezolizumab plus bevacizumab biomarker immune checkpoint inhibitors |
| title | Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma |
| title_full | Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma |
| title_fullStr | Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma |
| title_full_unstemmed | Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma |
| title_short | Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma |
| title_sort | comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma |
| topic | hepatocellular carcinoma immunotherapy atezolizumab plus bevacizumab biomarker immune checkpoint inhibitors |
| url | http://e-cmh.org/upload/pdf/cmh-2024-0628.pdf |
| work_keys_str_mv | AT binghuali comprehensiveanalysisoftranscriptomicbiomarkersforpredictingresponsetoatezolizumabplusbevacizumabimmunotherapyinhepatocellularcarcinoma AT jingyuanwen comprehensiveanalysisoftranscriptomicbiomarkersforpredictingresponsetoatezolizumabplusbevacizumabimmunotherapyinhepatocellularcarcinoma AT zhuxu comprehensiveanalysisoftranscriptomicbiomarkersforpredictingresponsetoatezolizumabplusbevacizumabimmunotherapyinhepatocellularcarcinoma AT pengyan comprehensiveanalysisoftranscriptomicbiomarkersforpredictingresponsetoatezolizumabplusbevacizumabimmunotherapyinhepatocellularcarcinoma AT binghan comprehensiveanalysisoftranscriptomicbiomarkersforpredictingresponsetoatezolizumabplusbevacizumabimmunotherapyinhepatocellularcarcinoma AT decaiyu comprehensiveanalysisoftranscriptomicbiomarkersforpredictingresponsetoatezolizumabplusbevacizumabimmunotherapyinhepatocellularcarcinoma |